Suppr超能文献

在 COVID-19 大流行期间对癌症患者的姑息治疗:来自 16 个国家的 36 项研究的叙述性综合。

Palliative care for cancer patients during the COVID-19 pandemic: A narrative synthesis from 36 studies of 16 countries.

机构信息

School of Medicine, Nantong University, Nantong, Jiangsu, PR China.

School of Public Health, Nantong University, Nantong, Jiangsu, PR China.

出版信息

J Clin Nurs. 2023 Sep;32(17-18):6120-6135. doi: 10.1111/jocn.16742. Epub 2023 May 22.

Abstract

BACKGROUND

During the COVID-19 epidemic, palliative care has become even more indispensable for cancer patients.

AIM

To identify the changes in palliative care for cancer patients and improvements in palliative care quality during the COVID-19 pandemic.

DESIGN

A systematic review and narrative synthesis was conducted in PubMed, Embase and Web of Science. An evaluation tool using mixed methods was used to assess the quality of the study. The main relevant themes identified were used to group qualitative and quantitative findings.

RESULTS

A total of 36 studies were identified, primarily from different countries, with a total of 14,427 patients, 238 caregivers and 354 health care providers. Cancer palliative care has been experiencing several difficulties following the COVID-19 pandemic, including increased mortality and infection rates as well as delays in patient treatment that have resulted in poorer prognoses. Treatment providers are seeking solutions such as electronic management of patients and integration of resources to care for the mental health of patients and staff. Telemedicine plays an important role in many ways but cannot completely replace traditional treatment. Clinicians strive to meet patients' palliative care needs during special times and improve their quality of life.

CONCLUSIONS

Palliative care faces unique challenges during the COVID-19 epidemic. With adequate support to alleviate care-related challenges, patients in the home versus hospital setting will be able to receive better palliative care. In addition, this review highlights the importance of multiparty collaboration to achieve personal and societal benefits of palliative care.

PATIENT OR PUBLIC CONTRIBUTION

No Patient or Public Contribution.

摘要

背景

在 COVID-19 疫情期间,姑息治疗对于癌症患者变得更加不可或缺。

目的

确定 COVID-19 大流行期间癌症患者姑息治疗的变化以及姑息治疗质量的提高。

设计

在 PubMed、Embase 和 Web of Science 中进行了系统评价和叙述性综合。使用混合方法评估工具来评估研究质量。主要相关主题用于对定性和定量发现进行分组。

结果

共确定了 36 项研究,主要来自不同国家,共有 14427 名患者、238 名照顾者和 354 名医疗保健提供者。COVID-19 大流行后,癌症姑息治疗面临着一些困难,包括死亡率和感染率增加,以及患者治疗延迟导致预后较差。治疗提供者正在寻找解决方案,例如电子管理患者和整合资源来照顾患者和员工的心理健康。远程医疗在许多方面发挥着重要作用,但不能完全替代传统治疗。临床医生努力在特殊时期满足患者的姑息治疗需求,提高他们的生活质量。

结论

姑息治疗在 COVID-19 大流行期间面临独特的挑战。通过充分的支持来缓解护理相关的挑战,在家中而非医院环境中的患者将能够获得更好的姑息治疗。此外,本综述强调了多方合作对于实现姑息治疗的个人和社会利益的重要性。

患者或公众贡献

无患者或公众贡献。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验